Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 230

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 230
---
 acknowledge and agree that notwithstanding that information may be provided in this Agreement (including the Schedules hereto) or the Disclosure 
 Letter under one particular heading of this Agreement that information will be considered to qualify any other relevant representation in or provide information in respect of any other relevant provision of this Agreement to the extent it is         
 reasonably apparent that such information is applicable to such other provision of this Agreement and such representation is so qualified by a reference to disclosure in writing.                                                                        |

| (b) | The Disclosure Letter itself and all information contained in it is confidential information and may not be                                                                                                                               
 disclosed unless (i) it is required to be disclosed pursuant to Law unless such Law permits the Parties to refrain from disclosing the information for confidentiality or other purposes or (ii) a Party needs to disclose it in order to 
 enforce or exercise its rights under this Agreement.                                                                                                                                                                                      |

| 1.7 | Schedules |

The following Schedules are annexed to and form an integral part of this Agreement: Schedule A – Plan of Arrangement Schedule B – Arrangement Resolution Schedule C – Representations and Warranties of the Purchaser and Parent A-18

Schedule D – Representations and Warranties of XRC Schedule E – Representations and Warranties of the Company Schedule F – Form of CVR Agreement ARTICLE 2 THE ARRANGEMENT

| 2.1 | Contemplated Transactions |

The Company and the Purchaser agree that the Contemplated Transactions shall be implemented in accordance with the terms and subject to the conditions of this Agreement and, with respect to the Arrangement and the Distribution, with the Plan of Arrangement.

| 2.2 | Interim Order |

As soon as reasonably practicable after the date of this Agreement, the Company shall apply in a manner acceptable to the Purchaser, acting reasonably, in accordance with Chapter XVI – Division II of the QBCA and, in cooperation with the Purchaser, prepare, file and diligently pursue an application for the Interim Order, which must provide, among other things:

| (a) | for the class(es) of persons to whom notice is to be provided in respect of the Arrangement and the Meeting and 
 for the manner in which such notice is to be provided;                                                          |

| (b) | that the required level of approval (the “Required Shareholder Approval”) for the 
 Arrangement Resolution shall be:                                                  |

| (i) | a special resolution, being a resolution approved by at least                                                                  
 two-thirds of the